Allez à nos transactions
Consommation et Détail | Soins de la Santé

Artisan Plastic Surgery and Artisan Beauté have been acquired by Olympus Cosmetic Group

Olympus Cosmetic Group, a platform providing comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures, has completed the acquisition of Artisan Plastic Surgery, LLC and Artisan Beauté, LLC (collectively Artisan), a female-founded and managed cosmetic surgery and medspa enterprise.

Artisan is a premier US cosmetic and reconstructive plastic surgery practice and luxury medspa business serving patients in the metro Atlanta region and beyond since 2000. Headquartered in Atlanta, Artisan operates four locations that provide leading-edge treatments to patients. Supported by a talented team of female surgeons, its highly complementary Artisan Beauté medspa locations provide patients with access to Artisan’s comprehensive and skillfully performed non-surgical aesthetic procedures.

Olympus is a provider of comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures located in Southeast USA. It is a portfolio company of VSS Capital Partners, which was founded in 1987 and is headquartered in New York. VSS is a private investment firm that invests in lower middle-market healthcare, business services and education companies.

Oaklins TM Capital in the USA served as the exclusive financial advisor to Artisan Plastic Surgery and Artisan Beauté in its sale to Olympus Cosmetic Group.

Parties prenantes
«For more than 20 years, Artisan has served the aesthetic needs of a loyal patient base throughout Atlanta and beyond. Dr. Wang-Ashraf and I take great pride in the quality of the practice we’ve built with the support of our close-knit and deeply talented colleagues. We needed a financial advisor that would appreciate what makes Artisan unique and help select the right type of acquiror to assist in building on our strengths. In Oaklins TM Capital, we found the ideal partner. Their deep industry relationships, experience with founder-owners and dedication to their clients gave us comfort through every step of this process. We appreciate the work the team did on our behalf, and we couldn’t be more excited about our partnership with Olympus and VSS.»

Dr. Diane Alexander

Founder, Artisan Plastic Surgery

Contacter l'équipe de la transaction

James S. Grien

Directeur général
Atlanta, États-Unis
Oaklins TM Capital

Michael S. Goldman

Directeur général
New York, États-Unis
Oaklins TM Capital

John Dean

Directeur associé
Atlanta, États-Unis
Oaklins TM Capital

Matthew Halbig

Analyste
Atlanta, États-Unis
Oaklins TM Capital

Alden Richards

Analyste
Atlanta, États-Unis
Oaklins TM Capital

Transactions connexes

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Soins de la Santé

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

En apprendre plus
Piper PE and Cool Japan Fund have backed a management buy-out of Inside Travel Group
Consommation et Détail

Piper PE and Cool Japan Fund have backed a management buy-out of Inside Travel Group

Inside Travel Group (ITG) has been sold to Piper PE and Cool Japan Fund. This acquisition aligns with ITG’s goal of becoming the leading specialist in tailor-made and group tours across Asia. Piper PE and Cool Japan Fund will continue to support ITG’s founders and management team, driving the business’ growth in Japan and other Asian destinations.

En apprendre plus
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Soins de la Santé

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

En apprendre plus